Circuit Therapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $4.5M

  • Investors
  • 5

Circuit Therapeutics General Information

Description

Operator of a biotechnology company intended for the discovery and development of transformational therapies. The company specializes in optogenetics which helps in specificity and temporal control of neural circuits for the development of first-in-class gene therapy and therapeutic discovery platforms, enabling researchers and clinicians the ability to control neural activity with light.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 1505 O'Brien Drive
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Circuit Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2020 $4.5M Completed Startup
1. Angel (individual) 01-Jan-2014 Completed Startup
To view Circuit Therapeutics’s complete valuation and funding history, request access »

Circuit Therapeutics Patents

Circuit Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190321473-A1 Minimally-invasive, high resolution neuromodulation of deep brain and cortical structures using circuit-specific promoters and focused ultrasound array Inactive 02-Apr-2018 00000000000
US-20190275169-A1 Targeted immunosuppression for optogenetic intervention Inactive 07-Mar-2018 00000000000 0
US-20190217129-A1 System and method for sonogenetic therapy Inactive 16-Jan-2018 00000000
US-20190217128-A1 System and method for sonogenetic therapy Inactive 16-Jan-2018 00000000
EP-3589208-A1 System for optogenetic therapy Inactive 02-Mar-2017 A61N5/0622
To view Circuit Therapeutics’s complete patent history, request access »

Circuit Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Fred Moll Chief Executive Officer & Chairman
Michael Kaplitt CSO
Rob Malenka Ph.D Co-Founder & Scientific Advisor
Karoly Nikolich Ph.D Co-Founder
Karl Deisseroth Ph.D Co-Founder & Scientific Advisor
You’re viewing 5 of 7 executive team members. Get the full list »

Circuit Therapeutics Board Members (1)

Name Representing Role Since
Fred Moll Circuit Therapeutics Chief Executive Officer & Chairman 000 0000
To view Circuit Therapeutics’s complete board members history, request access »

Circuit Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Defense Advanced Research Projects Agency Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
David Jeske Angel (individual) Minority 000 0000 000000 0
Scott Hassan Angel (individual) Minority 000 0000 000000 0
Stanford University School of Medicine University Minority 000 0000 000000 0
To view Circuit Therapeutics’s complete investors history, request access »

Circuit Therapeutics FAQs

  • When was Circuit Therapeutics founded?

    Circuit Therapeutics was founded in 2010.

  • Who is the founder of Circuit Therapeutics?

    Rob Malenka Ph.D, Karoly Nikolich Ph.D, Karl Deisseroth Ph.D, Scott Delp Ph.D, and Thomas Sudhof Ph.D are the founders of Circuit Therapeutics.

  • Who is the CEO of Circuit Therapeutics?

    Fred Moll is the CEO of Circuit Therapeutics.

  • Where is Circuit Therapeutics headquartered?

    Circuit Therapeutics is headquartered in Menlo Park, CA.

  • What industry is Circuit Therapeutics in?

    Circuit Therapeutics’s primary industry is Biotechnology.

  • Is Circuit Therapeutics a private or public company?

    Circuit Therapeutics is a Private company.

  • What is Circuit Therapeutics’s current revenue?

    The current revenue for Circuit Therapeutics is 000000.

  • Who are Circuit Therapeutics’s investors?

    Defense Advanced Research Projects Agency, United States Department of Defense, David Jeske, Scott Hassan, and Stanford University School of Medicine have invested in Circuit Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »